{
      "brief_title": [
            "new",
            "tablet",
            "contain",
            "two",
            "fda",
            "approve",
            "drug",
            "antiretroviral",
            "therapy",
            "experience",
            "infect",
            "subject"
      ],
      "brief_summary": [
            "study",
            "investigate",
            "safety",
            "effectiveness",
            "new",
            "compact",
            "formulation",
            "two",
            "already",
            "drug",
            "subject",
            "already",
            "receive",
            "treatment",
            "hiv",
            "infection"
      ],
      "detailed_description": [
            "phase",
            "iii",
            "randomize",
            "parallel",
            "multicenter",
            "study",
            "evaluate",
            "treatment",
            "combination",
            "versus",
            "abacavir",
            "lamivudine",
            "combination",
            "tenofovir",
            "new",
            "pi",
            "nnrti",
            "48",
            "week",
            "infect",
            "patient"
      ],
      "condition": [
            "immunodeficiency",
            "virus",
            "infection",
            "infection"
      ],
      "intervention_type": [
            "Drug",
            "Drug",
            "Drug",
            "Drug"
      ],
      "intervention_name": [
            "abacavir/lamivudine",
            "abacavir",
            "lamivudine",
            "tenofovir"
      ],
      "other_name": [],
      "criteria": [
            "inclusion",
            "criterion",
            "antiretroviral",
            "therapy",
            "art",
            "experience",
            "currently",
            "receive",
            "stable",
            "regimen",
            "contain",
            "3",
            "nucleoside",
            "reverse",
            "transcriptase",
            "inhibitor",
            "nrti",
            "2",
            "nrti",
            "plus",
            "protease",
            "inhibitor",
            "pi",
            "reverse",
            "transcriptase",
            "inhibitor",
            "nnrti",
            "least",
            "3",
            "month",
            "significant",
            "art",
            "modification",
            "least",
            "3",
            "month",
            "art",
            "change",
            "anticipate",
            "screen",
            "initiation",
            "study",
            "therapy",
            "patient",
            "must",
            "naive",
            "tenofovir",
            "rna",
            "level",
            "1000",
            "least",
            "one",
            "occasion",
            "within",
            "21",
            "day",
            "study",
            "entry",
            "cell",
            "count",
            "50",
            "specify",
            "viral",
            "genotype",
            "exclusion",
            "criterion",
            "pregnant",
            "woman",
            "active",
            "diagnosis",
            "aid",
            "additional",
            "qualify",
            "criterion",
            "determine",
            "physician"
      ],
      "gender": "All",
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": "No",
      "keyword": [
            "abacavir",
            "lamivudine",
            "tenofovir"
      ],
      "mesh_term": [
            "disease",
            "infection",
            "deficiency",
            "syndrome",
            "immunodeficiency",
            "syndrome"
      ],
      "id": "NCT00044577"
}